• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病患者肝髓系来源抑制细胞与临床病理参数的关系。

The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.

机构信息

Department of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Hospital of Xiamen University, Xiamen, Fujian, China.

出版信息

Biomed Res Int. 2021 Mar 29;2021:6612477. doi: 10.1155/2021/6612477. eCollection 2021.

DOI:10.1155/2021/6612477
PMID:33860040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8024072/
Abstract

Myeloid-derived suppressor cells (MDSCs) have attracted attention due to their important role in inflammation. Several studies have investigated the involvement of MDSCs in chronic liver disease. However, due to the difference of MDSC phenotypes, patient types, and sample sources among the studies, the results are inconsistent and controversial. We took advantage of a large well-defined cohort of 98 (24 patients with CHB, 18 with NAFLD, 13 with HCC, 16 with PBC, and 27 with AIH) patients with liver inflammation and 12 healthy controls to investigate the expression of MDSCs, and the relationships between the expression of hepatic MDSCs and the clinical characteristics were analyzed. We found that the expression of CD11b+CD33+ MDSCs is closely related to chronic liver disease and positively correlated with clinical parameters such as ALT, AST, and globulin. Ultimately, the present study suggests that hepatic CD11b+CD33+ MDSCs are increased in HCC and AIH and positively correlate with the liver stages of hepatitis activity and liver fibrosis stage.

摘要

髓系来源的抑制细胞(MDSCs)因其在炎症中的重要作用而引起关注。多项研究已经探讨了 MDSCs 在慢性肝病中的作用。然而,由于研究中的 MDSC 表型、患者类型和样本来源存在差异,研究结果不一致且存在争议。我们利用一个由 98 名(24 名慢性乙型肝炎患者、18 名非酒精性脂肪性肝病患者、13 名肝细胞癌患者、16 名原发性胆汁性胆管炎患者和 27 名自身免疫性肝炎患者)肝脏炎症患者和 12 名健康对照组成的大型明确队列,来研究 MDSCs 的表达,并分析肝 MDSCs 的表达与临床特征之间的关系。我们发现,CD11b+CD33+MDSCs 的表达与慢性肝病密切相关,与 ALT、AST 和球蛋白等临床参数呈正相关。最终,本研究表明,肝癌和自身免疫性肝炎中肝 CD11b+CD33+MDSCs 增加,并与肝炎活动的肝脏分期和肝纤维化分期呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/3db48ac506d5/BMRI2021-6612477.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/ffb65c596630/BMRI2021-6612477.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/bb9bf01e9dac/BMRI2021-6612477.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/3db48ac506d5/BMRI2021-6612477.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/ffb65c596630/BMRI2021-6612477.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/bb9bf01e9dac/BMRI2021-6612477.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38e/8024072/3db48ac506d5/BMRI2021-6612477.003.jpg

相似文献

1
The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.慢性肝病患者肝髓系来源抑制细胞与临床病理参数的关系。
Biomed Res Int. 2021 Mar 29;2021:6612477. doi: 10.1155/2021/6612477. eCollection 2021.
2
A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.半胱氨酸丰富蛋白 61 的功能特性:调节肝脏炎症中的髓源性抑制细胞。
Hepatology. 2018 Jan;67(1):232-246. doi: 10.1002/hep.29418. Epub 2017 Nov 17.
3
Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells.白细胞介素-35 通过诱导髓系来源的抑制细胞的扩增来调节自身免疫性肝炎的免疫微环境。
Front Immunol. 2019 Nov 7;10:2577. doi: 10.3389/fimmu.2019.02577. eCollection 2019.
4
Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.髓系来源的抑制细胞扩增与 HBV 相关慢加急性肝衰竭疾病严重程度和进展密切相关。
J Med Virol. 2019 Aug;91(8):1510-1518. doi: 10.1002/jmv.25466. Epub 2019 Apr 4.
5
CD33 CD14 CD11b HLA-DR monocytic myeloid-derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis.CCR9/CCL25 招募和激活的 CD33+CD14+CD11b+HLA-DR 单核细胞来源的髓系抑制细胞对于子宫内膜异位症的发病机制至关重要。
Am J Reprod Immunol. 2019 Jan;81(1):e13067. doi: 10.1111/aji.13067. Epub 2018 Nov 16.
6
Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.循环髓系来源的抑制细胞:乳腺癌患者的独立预后因素。
J Cell Physiol. 2019 Apr;234(4):3515-3525. doi: 10.1002/jcp.26896. Epub 2018 Oct 26.
7
CD45CD33CD11b myeloid-derived suppressor cells suppress CD8 T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer.CD45CD33CD11b 髓系来源的抑制细胞通过 IL-6/IL-8-精氨酸酶 I 轴抑制人胃癌中的 CD8 T 细胞活性。
Cell Death Dis. 2018 Jul 9;9(7):763. doi: 10.1038/s41419-018-0803-7.
8
The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.接受放疗的肝细胞癌患者中CD14(+)HLA-DR(-/低)髓源性抑制细胞的临床及预后意义
Tumour Biol. 2016 Aug;37(8):10427-33. doi: 10.1007/s13277-016-4916-2. Epub 2016 Feb 5.
9
Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.肝癌相关成纤维细胞通过促进髓系来源抑制细胞的产生来增强免疫抑制。
Oncogene. 2017 Feb 23;36(8):1090-1101. doi: 10.1038/onc.2016.273. Epub 2016 Sep 5.
10
Distinct alterations of CD68CD163 M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment.大剂量地塞米松治疗后初诊原发性免疫性血小板减少症患者伴或不伴有完全反应者中 CD68CD163 M2 样巨噬细胞和髓系来源抑制细胞的明显改变。
J Transl Med. 2018 Mar 2;16(1):48. doi: 10.1186/s12967-018-1424-8.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis.肝损伤时髓系来源的抑制性细胞在肝脏中的募集促进肝再生和纤维化。
BMC Gastroenterol. 2024 May 14;24(1):163. doi: 10.1186/s12876-024-03245-4.
3
A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation.

本文引用的文献

1
Hyal2 Expression in Tumor-Associated Myeloid Cells Mediates Cancer-Related Inflammation in Bladder Cancer.Hyal2 在肿瘤相关髓系细胞中的表达介导膀胱癌中的癌症相关炎症。
Cancer Res. 2021 Feb 1;81(3):648-657. doi: 10.1158/0008-5472.CAN-20-1144. Epub 2020 Nov 25.
2
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.一种用于肝细胞癌的新的候补者退出评分 - 确定一个可预测移植后生存状况更差的阈值。
J Hepatol. 2021 Apr;74(4):829-837. doi: 10.1016/j.jhep.2020.10.033. Epub 2020 Nov 11.
3
Nox1/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertension.
高脂肪饮食通过诱导肠道微生物群介导的亮氨酸产生和 PMN-MDSC 分化促进癌症进展。
Proc Natl Acad Sci U S A. 2024 May 14;121(20):e2306776121. doi: 10.1073/pnas.2306776121. Epub 2024 May 6.
4
Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients.在肝硬化患者中,MDSC 的存在与 COVID-19 疫苗接种后抗原特异性 T 细胞反应受损有关。
Front Immunol. 2023 Oct 20;14:1287287. doi: 10.3389/fimmu.2023.1287287. eCollection 2023.
5
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells.原发性肝癌的免疫图谱和免疫治疗:聚焦固有免疫和适应性免疫细胞。
Clin Exp Med. 2023 Oct;23(6):1881-1899. doi: 10.1007/s10238-023-01015-2. Epub 2023 Feb 11.
6
Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis.粒细胞-巨噬细胞集落刺激因子调节失代偿期肝硬化合并脓毒症患者髓源性抑制细胞和 Treg 活性。
Front Immunol. 2022 Jun 3;13:828949. doi: 10.3389/fimmu.2022.828949. eCollection 2022.
7
Clinical perspectives on the age-related increase of immunosuppressive activity.临床视角下与年龄相关的免疫抑制活性增加。
J Mol Med (Berl). 2022 May;100(5):697-712. doi: 10.1007/s00109-022-02193-4. Epub 2022 Apr 6.
8
Neutrophils in chronic inflammatory diseases.慢性炎症性疾病中的中性粒细胞。
Cell Mol Immunol. 2022 Feb;19(2):177-191. doi: 10.1038/s41423-021-00832-3. Epub 2022 Jan 17.
Nox1/4 抑制加剧自发性高血压模型中与年龄相关的血管周围炎症和纤维化。
Pharmacol Res. 2020 Nov;161:105235. doi: 10.1016/j.phrs.2020.105235. Epub 2020 Oct 22.
4
Viral hepatitis and pregnancy.病毒性肝炎与妊娠。
Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):117-130. doi: 10.1038/s41575-020-00361-w. Epub 2020 Oct 12.
5
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.先天淋巴细胞:肝脏疾病和癌症的发病机制和治疗靶点。
Cell Mol Immunol. 2021 Jan;18(1):57-72. doi: 10.1038/s41423-020-00561-z. Epub 2020 Oct 12.
6
Osteopontin Takes Center Stage in Chronic Liver Disease.骨桥蛋白在慢性肝病中占据中心舞台。
Hepatology. 2021 Apr;73(4):1594-1608. doi: 10.1002/hep.31582.
7
Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality.非酒精性脂肪性肝病相关慢加急性肝衰竭:发病率和病死率均升高的老年患者群体
Hepatology. 2021 May;73(5):1932-1944. doi: 10.1002/hep.31566. Epub 2021 Mar 25.
8
Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice.MitoTEMPO 通过调节髓系来源的抑制细胞和炎症对非酒精性脂肪肝病的保护作用。在小鼠中。
Biomed Res Int. 2020 Jul 30;2020:9329427. doi: 10.1155/2020/9329427. eCollection 2020.
9
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease.肠道微生物群的调节介导小檗碱诱导免疫抑制细胞扩增以对抗酒精性肝病。
Clin Transl Med. 2020 Aug;10(4):e112. doi: 10.1002/ctm2.112. Epub 2020 Aug 13.
10
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease.在体外,胆管癌衍生的细胞因子可扩增抑制性髓系细胞,并与侵袭性疾病相关。
Br J Cancer. 2020 Oct;123(9):1377-1386. doi: 10.1038/s41416-020-1018-0. Epub 2020 Aug 4.